Current technologies for isolating circulating tumor cells (CTCs) have limited prognostic value because of the low sensitivities, yields and purities associated with these methods. Nagrath et al.

CTC are outnumbered by red blood cells and leukocytes in the blood ... these clinical samples is often required to obtain pure tumor populations that will allow accurate detection, measurement ...

Cancer is the leading cause of death globally, with nearly 20 million new cases and 9.7 million deaths in 2022. Due to its ...

Dublin, April 03, 2025 (GLOBE NEWSWIRE) -- The "Circulating Tumor Cell Market by Technology Type (CTC Analysis, CTC Detection & Isolation), Product Type (Instruments, Kits & Reagents), Application ...

Liquid biopsies broadly refer to the isolation of both cellular and ... Although protein-based testing and testing of circulating tumor cells are options, the bulk of promising research in bladder ...

Two examples of nanotechnology in this area: rather than using magnetic and microfluidic methods for the isolation of CTCs, researchers have demonstrated a carbon nanotube chip that captures and ...

In collaboration with nano-technology engineers, we developed the “NanoFlare” method that enables the detection and isolation of live circulating tumor cells (CTC), establishing a platform to study ...

Human circulating tumor DNA “was overall consistently shorter than the fragment length of normal cell-free DNA,” the authors wrote in their paper. The findings could help improve cancer diagnosis and ...

Cancer is one of the leading causes of death globally, with nearly 20 million new cases and 9.7 million deaths in 2022.

Somewhere in the body of a patient, a small clump of cells, growing undetected, has begun to form a tumor. It has yet to ...